Australian vaccine provides protection against infection, safe for humans
A potential COVID-19 vaccine developed in Australia has shown positive ends up in human clinical trials. The vaccine candidate has shown zero side effects in human trials thus far and has shown promising results when tried on animals. Australian vaccine provides protection against infection, safe for humans.
In July, the University of Queensland (UQ) and Australian biotech giant CSL began the trial with injecting 120 Brisbane volunteers with the potential shot against the novel coronavirus infection, DailyMail reported.
After the primary trial doses were administered on animals, project co-leader prof Keith Chappell said it had been successful.
From phase II of the Oxford COVID-19 vaccine starting in Pune to World Health Organisation (WHO) chief scientist saying that a ‘fair distribution’ of a vaccine is an enormous challenge, here are all the newest updates on the coronavirus vaccine and its candidates:
Phase II human trial of Oxford vaccine begins in India, two volunteers administered first shot
Two volunteers were administered a COVID-19 vaccine developed by the University of Oxford as a part of its clinical trial trials at Bharti Vidyapeeth’s Medical College and Hospital in Pune.
Pune-based Serum Institute of India has partnered with AstraZeneca to manufacture the vaccine, named Covishield.
“Five volunteers were tested for RT-PCR and antibodies, out of which reports of three showed they need anti-bodies, hence the vaccine was administered to 2,” Medical Director of Bharti Vidyapeeth’s Medical Hospital said.
Fair distribution of COVID-19 vaccine a giant challenge: WHO Chief Scientist Soumya Swaminathan
Distributing COVID-19 vaccine round the world fairly without letting the rich countries corner the limited doses goes to be a giant challenge, the WHO’s Chief Scientist Soumya Swaminathan said on August 26.
On vaccine development for the novel coronavirus, she said: “By early 2021, we should always have some excellent news.”
Then, there’s the massive challenge of having the ability to scale, distribute, and allocate fairly around the world without letting the rich countries corner the limited doses, Swaminathan said.
Cambridge University kicks off vaccine race to fight all coronaviruses
The University of Cambridge on August 26 confirmed plans to start trials of a possible new vaccine not only against COVID-19 but all coronaviruses that will spill over from animals to humans within the future.
The new vaccine candidate, DIOS-CoVax2, uses banks of genetic sequences of all known coronaviruses, including those from bats, believed to be the natural hosts of the many relatives of human coronaviruses.
A vaccine that clears all trials can then be delivered pain-free without a needle into the skin through a spring-powered jet injection.
A version of this article was originally published on https://www.moneycontrol.com/news/india/coronavirus-vaccine-update-australian-candidate-shows-promise-fair-distribution-of-vaccine-big-challenge-says-who-5760411.html